This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

World Congress On Interventional Oncology To Present Live TheraSphere® Administration

Dr. Riad Salem, Yttrium-90 radioembolization expert, to narrate liver cancer treatment in Chicago

OTTAWA, June 14, 2012 /PRNewswire/ - Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced that organizers of the World Congress on Interventional Oncology (WCIO) 2012 will be hosting a live administration of Nordion's TheraSphere ® Yttrium-90 (Y-90) glass microsphere liver cancer treatment.

The administration will take place on Thursday, June 14 at 5 PM CST in the context of an approved Continuing Medical Education program organized by WCIO. The treatment will be administered to a pre-screened patient at Northwestern Memorial Hospital ( Northwestern University) in Chicago and broadcast live via video link to physicians attending WCIO, which takes place in Chicago June 14-17. Real-time narration of the procedure will be provided by Riad Salem, MD, Professor of Radiology, Medicine and Surgery and Director, Interventional Oncology at Northwestern University, and one of the world's foremost experts in Y-90 radioembolization for liver cancer.

"We are pleased with WCIO's initiative to present a live case demonstration of TheraSphere®," said Mason Ross, MD, Nordion's Vice President of Medical Affairs. "This promises to be a valuable and unique learning opportunity for physicians considering the use of TheraSphere®.  Observers will be able to see first-hand how generally well-tolerated and fast the infusion is as a liver-directed therapy."

Nordion representatives attending WCIO will be at Booth #208 to meet with physicians and journalists. Among other topics, Nordion will be providing more information on the new TheraSphere ® custom dose feature, which was launched last month in Canada and the EU and is now available in the US. In addition, Nordion will be demonstrating the new TheraSphere ® App for iPad, created for healthcare providers and now available for download through the Apple App Store and iTunes. Nordion is also providing $20,000 to the WCIO Fellows' Scholarship Fund, which provides interventional radiology fellows training in the latest interventional oncology techniques, therapies, and research presented by multidisciplinary international faculty.

About TheraSphere ® TheraSphere ® is a liver cancer therapy that consists of millions of small glass beads (20 to 30 micrometers in diameter) containing radioactive Y-90. The product is injected by physicians into the artery of the patient's liver through a catheter, which allows the treatment to be delivered directly to the tumour via blood flow.

In the US, TheraSphere ® is used to treat patients with HCC who can have appropriately positioned hepatic arterial catheters, and can be used as a bridge to surgery or transplantation in these patients.  It is also indicated for the treatment of HCC patients with partial or branch portal vein thrombosis or occlusion when clinical evaluation warrants the treatment.  TheraSphere ® is approved by the U.S. Food and Drug Administration (FDA) under a Humanitarian Device Exemption (HDE). HDE approvals are based on demonstrated safety and probable clinical benefit. However, effectiveness of the indication for use has not been established.

Common side effects include mild to moderate fatigue, pain and nausea for about a week. Physicians describe these symptoms as similar to those of the flu. Some patients experience some loss of appetite and temporary changes in several blood tests. For details on rare or more severe side effects, please refer to the TheraSphere ® package insert/instructions for use at

About Nordion Inc.  Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of medical isotopes, targeted therapies and sterilization technologies that benefit the lives of millions of people in more than 60 countries around the world. Our products are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Nordion has more than 500 highly skilled employees in three locations. Find out more at and follow us at

SOURCE Nordion Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.72 -0.56%
FB $119.49 1.43%
GOOG $711.12 1.38%
TSLA $214.93 1.61%
YHOO $37.23 0.79%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs